Emerging Markets

Seize opportunities now

Thanks to their rapid economic growth and positive future prospects, the Emerging Markets outside the established ICH regions (USA, EU, Japan) have become the focus for business expansion.

The marketing authorisation requirements in these emerging markets are still relatively "moderate". In most cases these requirements can be fulfilled using the same documentation as was submitted within Europe.

Hence it is possible to exploit the available opportunities in these markets relatively quickly. In this connection our team in Karlsruhe can provide close support based on its extensive experience of the pharmaceutical industry. We will evaluate your dossiers with regard to specific national requirements (due diligence; content-related and formal aspects), advise you during the planning phase, and then successfully guide your products to marketing authorisation. Naturally, we can also assume responsibility for lifecycle management in these markets.